IFITM3 expression is positively correlated with cancer stage and differentiation status with higher expression levels in invasive ductal carcinomas as compared to ductal carcinoma in-situs (25) and non-differentiated lung cancers as compared to well-differentiated lung cancers (27). This evidence concerns the gene IFITM3 and cancer.